Загрузка...
Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β‐catenin signaling and sensitizes cancer cells to FH535 therapy
The incidence of thyroid cancer has increased worldwide at a rate higher than that of any other cancer. CSN6 is overexpressed in many types of cancers, and such expression is linked to oncogenic activity. However, the detailed biological functions of CSN6 in papillary thyroid cancer (PTC) have not b...
Сохранить в:
| Опубликовано в: : | Cancer Med |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5806103/ https://ncbi.nlm.nih.gov/pubmed/29341469 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1272 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|